Drugmakers race to find a place in the next wave of obesity drugs
· cnbc.com
Drugmakers are betting they can crack into the obesity drug market that Novo Nordisk and Eli Lilly currently dominate.
Drugmakers are only months into introducing GLP-1 pills and navigating huge changes in how patients pay for weight-loss drugs.
Even so, they're already outlini...